CANNONE, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 2.957
AS - Asia 2.616
EU - Europa 1.010
SA - Sud America 352
AF - Africa 123
Continente sconosciuto - Info sul continente non disponibili 96
OC - Oceania 6
Totale 7.160
Nazione #
US - Stati Uniti d'America 2.884
SG - Singapore 978
CN - Cina 726
VN - Vietnam 382
BR - Brasile 282
IE - Irlanda 278
HK - Hong Kong 200
SE - Svezia 137
IT - Italia 113
DE - Germania 93
ZA - Sudafrica 92
TR - Turchia 81
FR - Francia 80
NL - Olanda 79
BD - Bangladesh 59
CA - Canada 43
FI - Finlandia 41
RU - Federazione Russa 39
IN - India 34
GB - Regno Unito 32
AR - Argentina 30
PL - Polonia 24
JP - Giappone 22
TW - Taiwan 20
BE - Belgio 18
AT - Austria 17
MX - Messico 16
IQ - Iraq 15
PK - Pakistan 13
ES - Italia 12
EC - Ecuador 11
ID - Indonesia 11
UA - Ucraina 10
UZ - Uzbekistan 10
PH - Filippine 9
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
KR - Corea 7
LT - Lituania 7
PE - Perù 7
MA - Marocco 6
SA - Arabia Saudita 6
MY - Malesia 5
TH - Thailandia 5
AL - Albania 4
AZ - Azerbaigian 4
DZ - Algeria 4
EG - Egitto 4
KE - Kenya 4
OM - Oman 4
RO - Romania 4
TN - Tunisia 4
CR - Costa Rica 3
JM - Giamaica 3
LB - Libano 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
AU - Australia 2
BO - Bolivia 2
BW - Botswana 2
CH - Svizzera 2
CL - Cile 2
HN - Honduras 2
HU - Ungheria 2
IL - Israele 2
JO - Giordania 2
KG - Kirghizistan 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
NP - Nepal 2
PS - Palestinian Territory 2
RS - Serbia 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CV - Capo Verde 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GR - Grecia 1
IR - Iran 1
LU - Lussemburgo 1
MZ - Mozambico 1
NC - Nuova Caledonia 1
NI - Nicaragua 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 7.062
Città #
Singapore 438
Ashburn 356
San Jose 319
Santa Clara 304
Dublin 277
Chandler 264
Beijing 233
Hong Kong 192
Dallas 139
Ann Arbor 128
Ho Chi Minh City 116
Boardman 103
Council Bluffs 88
Dearborn 88
Johannesburg 83
Nanjing 81
Izmir 70
Hanoi 68
Princeton 61
Lauterbourg 59
Houston 43
Wilmington 42
Los Angeles 40
New York 37
Shanghai 33
São Paulo 29
Moscow 28
Woodbridge 28
Helsinki 27
Kunming 27
Seattle 25
Bremen 23
Da Nang 23
Frankfurt am Main 21
Parma 21
Warsaw 21
Columbus 19
Munich 19
Nanchang 19
Tokyo 19
Brussels 18
Fremont 18
Shenyang 18
Haiphong 17
Hefei 17
Tianjin 16
Changsha 15
Montreal 15
Chicago 14
Hebei 14
Jiaxing 14
Nuremberg 14
Turku 14
Brooklyn 13
Milan 13
Taipei 13
The Dalles 13
Buffalo 12
Vienna 12
Boston 11
Guangzhou 11
Jinan 11
Rio de Janeiro 11
Tashkent 10
San Mateo 9
Atlanta 8
Biên Hòa 8
Bologna 8
Hải Dương 8
Norwalk 8
Orem 8
Porto Alegre 8
Redmond 8
Can Tho 7
Florence 7
Phoenix 7
Reggio Emilia 7
Rockville 7
San Francisco 7
Stockholm 7
Thái Nguyên 7
Amsterdam 6
Baghdad 6
Belo Horizonte 6
Fortaleza 6
Jakarta 6
London 6
Mexico City 6
Ottawa 6
Pune 6
Wuhan 6
Borås 5
Brasília 5
Bắc Giang 5
Campinas 5
Chengdu 5
Chennai 5
Curitiba 5
Denver 5
Des Moines 5
Totale 4.579
Nome #
Concurrent heterozygous Von-Hippel-Lindau and transmembrane-protein-127 gene mutation causing an erythropoietin-secreting pheochromocytoma in a normotensive patient with severe erythrocytosis 227
Electrolyte Disorders Induced by Antineoplastic Drugs 195
Atrial natriuretic peptide: A molecular target of novel therapeutic approaches to cardio-metabolic disease 188
Evidence for a Prehypertensive Water Dysregulation Affecting the Development of Hypertension: Results of Very Early Treatment of Vasopressin V1 and V2 Antagonism in Spontaneously Hypertensive Rats 173
NT-proBNP, race and endothelial function in the Multi-Ethnic Study of Atherosclerosis 158
Posterior reversible encephalopathy syndrome in an oncological normotensive patient: Evidence for a pathogenic role of concomitant low magnesium serum levels and chemotherapy treatment 152
Aging and oral health: Effects in hard and soft tissues 137
Bisphosphonate-associated femoral fracture: Implications for management 129
Association of NPPA rs5065 Genetic Variant With Increased Cardiovascular Risk in the General USA Population 128
Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: A 9-year follow-up study 127
Aldosterone, Cardiorenal and Metabolic Disease in a General Community in Olmsted County, Minnesota: Biomarker and/or Mediator 125
Aldosterone in the General Community: Biomarker or Mediator of Cardiorenal and Metabolic Disease 125
A cardiometabolic protective phenotype associated with the ANP genetic variant rs5068 in African Americans: the Multi-Ethnic Study of Atherosclerosis (MESA) 124
A favorable cardiometabolic profile is associated with the G allele of the genetic variant rs5068 in African Americans: The Multi-Ethnic Study of Atherosclerosis (MESA) 121
Aldosterone, Hypertension, and Antihypertensive Therapy: Insights From a General Population 120
Aldosterone predicts cardiovascular, renal, and metabolic disease in the general community: A 4-year follow-up 120
A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community 119
An update on rickettsiosis 115
MANP in Hypertension With Metabolic Syndrome: Proof-of-Concept Study of Natriuretic Peptide-Based Therapy for Cardiometabolic Disease 112
Evidence for Angiotensin II as a Naturally Existing Suppressor for the Guanylyl Cyclase A Receptor and Cyclic GMP Generation 112
Predictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: A 9-year follow-up study 111
A cardio-metabolic phenotype in carriers of NPPA (rs5086) and NPPB (rs198389) gene variants in the general population: the dominant role of ANP 111
A Genetic Variant of the ANP Gene Is Associated With a Lower Cardiometabolic Risk Profile in the General USA Population 111
An atrial natriuretic peptide genetic variant (rs5065) in the general US population identifies risk for cerebrovascular accidents 109
Aldosterone: Marker and Predictor of Cardiorenal and Metabolic Disease in the General Community 109
Aldosterone Level in the General Community Predicts New Onset Cardiometabolic Disease 107
A genetic variant of the NPPA gene (rs5068) is associated with increased NT-ANP levels and reduced cardiometabolic risk 106
The Anp genetic variant Rs5068 and circulating levels of natriuretic peptides in patients with chronic heart failure 106
Natriuretic peptide pathways in heart failure: further therapeutic possibilities 105
Hypokalemic rhabdomyolysis in a patient with a laparoscopic adjustable gastric banding 104
FokI polymorphism of the vitamin D receptor gene correlates with parameters of bone mass and turnover in a female population of the Italian island of Lampedusa 100
Differential Regulation of ANP and BNP in Acute Decompensated Heart Failure: Deficiency of ANP 99
MANP: A novel designer natriuretic peptide GC-A activator for the treatment of hypertension and heart failure 97
PRESENCE OF A NATRIURETIC PEPTIDE DEFICIENCY STATE AMONGST PATIENTS DIAGNOSED WITH HYPERTENSION 97
DIFFERENTIAL REGULATION OF CIRCULATING CARDIAC NATRIURETIC PEPTIDES IN HUMAN ACUTE DECOMPENSATED HEART FAILURE: EVIDENCE FOR A SELECTIVE AND RELATIVE ATRIAL NATRIURETIC PEPTIDE DEFICIENCY 95
A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart Failure 95
Chronic Renal Insufficiency: Prevalence in the General Population and Improved Detection of Cardiac Disease in Combination with BNP Assays 94
Metabolic disease in the general population: a potential cyclic GMP deficiency states 93
Can a cardiac peptide predict mortality in human hypertension? 92
Circulating aldosterone predicts future cardiorenal and metabolic disease in the general community 92
The BNP genetic variant rs198389: cardiovascular phenotype and risk in stage A/B heart failure subjects from the STOP-HF Trial 91
Mineral bone diseases and thermal walter therapy hot mud bath 90
IN-DEPTH PHENOTYPE OF SUBJECTS WITH INCREASED HEART FAILURE RISK BASED ON B-TYPE NATRIURETIC PEPTIDE 90
CHARACTERIZATION OF ANP GENETIC VARIANT RS5068 IN CHRONIC HEART FAILURE PATIENTS 90
Sex-based differences in metabolic protection by the ANP genetic variant rs5068 in the general population 84
Divergent effects of a designer natriuretic peptide CD-NP in the regulation of adipose tissue and metabolism 84
THE BNP GENETIC VARIANT RS198389: HYPERTENSION RISK AND CARDIOVASCULAR PHENOTYPE IN STAGE A AND STAGE B HEART FAILURE SUBJECTS FROM THE STOP-HF TRIAL 84
Insulin/glucose induces natriuretic peptide clearance receptor in human adipocytes: A metabolic link with the cardiac natriuretic pathway 83
Differences in Natriuretic Peptide Levels by Race/Ethnicity (From the Multi-Ethnic Study of Atherosclerosis) 83
MANP: A Novel Designer Natriuretic Peptide for Cardiometabolic Disease 83
In Vitro and In Vivo Actions of a Novel ANP Genetic Variant: Unique Actions on Human Endothelial Cells 83
Evidence of autonomic dysregulation in otherwise healthy cancer caregivers: A possible link with health hazard 82
Plasma Aldosterone and Heart Failure in the General Community 81
Circulating molecular forms of ANP and BNP in human acute decompensated heart failure: evidence for a relative ANP deficiency state 80
The atrial natriuretic peptide genetic ariant rs5068 is associated with a favorable cardiometabolic phenotype in a mediterranean population 80
Metformin-induced lactic acidosis in a type 2 diabetic patient with acute renal failure 80
The malnutrition in the elderly: A clinical approach 79
Circulating cGMP plasma levels in cardiovascular and renal diseases: new insights from the general community 79
The Soluble Guanylate Cyclase Genetic Variant rs13139571 Is Associated with an “Unfavorable” Metabolic Phenotype in an US General Community 79
Circulating cGMP Levels in the General Population: Relationship with Cardiovascular and Renal Diseases 77
Natriuretic Peptides and Blood Pressure Homeostasis: Implications for MANP, a Novel Guanylyl Cyclase a Receptor Activator for Hypertension 76
Circulating aldosterone and natriuretic peptides in the general community relationship to cardiorenal and metabolic disease 76
Circulating corin in the general community: link to gender and metabolic dysfunction 76
STOP-HF Trial: Higher Endogenous BNP and Cardiovascular Protection in Subjects at Risk for Heart Failure 75
First-in-Human Study of MANP: A Novel ANP (Atrial Natriuretic Peptide) Analog in Human Hypertension 74
The ANP Genetic Variant rs5068 Is Associated with Higher Circulating Concentrations of Natriuretic Peptides in Patients with Chronic Heart Failure 73
The role of OPG, RANK, RANKL in the bone metabolism, cardiovascular disease and immune system: Clinical and physiopathological implication 73
Circulating Corin in the General Community: A Link to Gender and Metabolic Phenotype 70
Necrotizing fasciitis of the face: A life-threatening condition 65
Totale 7.160
Categoria #
all - tutte 28.315
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.315


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022217 0 7 4 4 7 2 17 28 11 13 9 115
2022/2023962 109 87 20 72 94 87 7 89 341 2 31 23
2023/2024353 29 34 14 13 41 71 16 34 17 22 31 31
2024/20251.553 5 74 92 55 206 263 33 66 207 160 110 282
2025/20262.961 284 288 399 205 416 127 372 72 409 233 84 72
2026/2027172 62 110 0 0 0 0 0 0 0 0 0 0
Totale 7.160